Tel: 866-662-2852
Bayer AG on Tuesday disclosed another jump in the number of lawsuits alleging the German company's recently-acquired weed killers cause cancer in a sign that an issue that has wiped billions off Bayer's market valuation isn't fading away. Lawsuits from 9,300 plaintiffs were pending at the end of October, compared with 8,700 at the end of August, Bayer said.
